44 min listen
Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk
FromThe Exchange
Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk
FromThe Exchange
ratings:
Length:
47 minutes
Released:
May 27, 2020
Format:
Podcast episode
Description
Another rally on Wall Street and two strategists both say there’s more room to run…where they’re finding opportunities.The CEO of AbCellera joins to discuss the company’s partnership with Eli Lilly in the race for a COVID-19 antibody drug.And two policy strategists weigh in one of the biggest and most underappreciated risks for the market right now.Plus, a ‘cool’ trade for the summer.
Released:
May 27, 2020
Format:
Podcast episode
More Episodes from The Exchange
Rate debate, un-welcoming party?, and Credit Suisse bets on bubbles: We’re just an hour away from getting the minutes from the latest Fed meeting, where the FOMC started to sound hawkish. We’ll debate which way rates go next. Plus, Chinese stocks are selling off again today. Did U.S. investors overestimate how committed China was to capitalism? We’ll explore how ‘welcoming’ (or not) it’s becoming to outside investors. And, in today’s Rapid Fire: more people are paying with crypto, some people are working less but getting paid the same, and Credit Suisse is betting more people will begin drinking hard seltzer. by The Exchange